WallStreetZenWallStreetZen

NASDAQ: MLYS
Mineralys Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Mineralys Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MLYS annual revenue was $0.0, with N/A growth year-over-year.

MLYS revenue history

Current Revenue
$0.0
Current Earnings
-$177.8M
Current Profit Margin
0%

Be the first to know when MLYS announces revenue.

MLYS Revenue History By Year

MLYS Yearly RevenueMLYS RevenueMLYS ChangeMLYS Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A

1 of 1

Mineralys Therapeutics Revenue FAQ

What was MLYS's revenue last quarter?

Mineralys Therapeutics (NASDAQ: MLYS) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Mineralys Therapeutics's revenue was $0.00.

What was Mineralys Therapeutics's revenue in 2024?

Mineralys Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Mineralys Therapeutics make in a day?

Based on Mineralys Therapeutics annual revenue for the past four years, MLYS makes an average of $0.00 per day.

What was Mineralys Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Mineralys Therapeutics's revenue has grown null year over year. Mineralys Therapeutics's revenue in the past year totaled $0.00.

How much does Mineralys Therapeutics make in a year?

Mineralys Therapeutics's revenue by year for the past four years is:
  • Mineralys Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Mineralys Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Mineralys Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Mineralys Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.